| __timestamp | ADMA Biologics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 1271353000 |
| Thursday, January 1, 2015 | 7015946 | 1620577000 |
| Friday, January 1, 2016 | 7688238 | 2052295000 |
| Sunday, January 1, 2017 | 6229587 | 2075142000 |
| Monday, January 1, 2018 | 3926120 | 2186100000 |
| Tuesday, January 1, 2019 | 2343848 | 3036600000 |
| Wednesday, January 1, 2020 | 5907013 | 2735000000 |
| Friday, January 1, 2021 | 3646060 | 2908100000 |
| Saturday, January 1, 2022 | 3613764 | 3592500000 |
| Sunday, January 1, 2023 | 3300000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outpaced ADMA Biologics, Inc. in R&D investment. From 2014 to 2023, Regeneron's R&D expenses surged by approximately 250%, reaching a peak of $4.4 billion in 2023. In contrast, ADMA's R&D budget saw a decline of about 65%, dropping to $3.3 million in the same year.
This stark contrast highlights Regeneron's commitment to innovation, as it invests heavily in developing new therapies and maintaining its competitive edge. Meanwhile, ADMA's reduced spending may reflect strategic shifts or financial constraints. As the biotech landscape evolves, these R&D trends offer valuable insights into the strategic priorities and future trajectories of these two companies.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and ImmunityBio, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How United Therapeutics Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs ADMA Biologics, Inc.
ADMA Biologics, Inc. or MannKind Corporation: Who Invests More in Innovation?
R&D Spending Showdown: ADMA Biologics, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Novavax, Inc.